Search

Search Constraints

You searched for: Author/Creator Horowitz, Mary M.

Search Results

1. Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. Issue 11 (24th January 2017)

2. Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation. Issue 23 (10th August 2021)

4. Centralized patient‐reported outcome data collection in transplantation is feasible and clinically meaningful. Issue 23 (17th August 2017)

5. Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell Transplantation. Issue 3 (April 2019)

6. Health‐related quality of life in reduced‐intensity hematopoietic cell transplantation based on donor availability in patients aged 50–75 with advanced myelodysplastic syndrome: BMT CTN 1102. Issue 2 (21st November 2022)

7. National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide. Issue 18 (20th June 2021)

8. Patient‐reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902). Issue 1 (6th October 2015)

9. PROMIS measures can be used to assess symptoms and function in long‐term hematopoietic cell transplantation survivors. Issue 4 (26th October 2017)

10. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. Issue 4 (1st February 2022)